Author: SmartStocks.ca Staff
-
DexCom Stock Falls After Underwhelming Q3 Earnings

Dexcom, Inc. (Nasdaq: DXCM) reported disappointing third-quarter 2024 earnings on Thursday, revealing just 2% revenue growth year-over-year to $994.2 million. This slow revenue expansion—particularly driven by a 2% decline in U.S. revenue—comes as the stock continues to trade at an elevated 46 times earnings, raising concerns about its valuation given the lack of strong growth. Read more
-
McDonald’s Stock Declines Amid E. coli Outbreak: Should Investors Stay the Course?

Recent reports have linked an E. coli outbreak to McDonald’s (NYSE:MCD) quarter pounders, resulting in 49 illnesses. One person has died from the outbreak. This has triggered a temporary removal of the popular burger from some locations, causing the stock to fall. For McDonald’s, the news comes before it releases its latest earnings numbers, and Read more
-
CVS Health Changes Leadership Amid Financial Struggles

CVS Health replaced its CEO, Karen Lynch, with David Joyner as the company faces financial challenges, especially with its Aetna insurance business. CVS warned that its Q3 earnings will miss expectations, causing shares to drop by more than 7% on Friday morning. The company’s stock has fallen 19% this year, leading to the leadership shift. Read more
-
Netflix Beats Earnings Expectations in Q3 as Advertising Tier Shows Strong Growth

Netflix (NASDAQ:NFLX) released a strong Q3 2024 report on Thursday, exceeding expectations with $9.8 billion in revenue and $5.40 earnings per share. The company’s ad-supported tier saw a 35% increase in memberships, driving more than half of new sign-ups in available markets. Subscriber growth also impressed, adding 5.1 million new users, bringing the total to Read more
-
TD Bank Faces Historic $3 Billion Fine

Toronto-Dominion Bank (TSX:TD) faces a record $3.09 billion USD penalty after pleading guilty to significant U.S. money-laundering charges. U.S. authorities found that systemic breakdowns in TD’s transaction monitoring allowed over $670 million in illicit funds to flow through its branches. In addition to the fine, regulators imposed growth restrictions on TD’s U.S. operations, further complicating Read more
